Luo, J. (2016). Development of AR-V7 as a putative treatment selection marker for metastatic castration-resistant prostate cancer. Asian J Androl.
استشهاد بنمط شيكاغوLuo, Jun. "Development of AR-V7 As a Putative Treatment Selection Marker for Metastatic Castration-resistant Prostate Cancer." Asian J Androl 2016.
MLA استشهادLuo, Jun. "Development of AR-V7 As a Putative Treatment Selection Marker for Metastatic Castration-resistant Prostate Cancer." Asian J Androl 2016.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.